GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Lab] SGN survo — VendorInvestigate came back 99.0% against a claimed 99.1% — 66 comments in the full submission. View in context.
761
c/survodutide·submitted 9 months ago by u/elin_ferrari

[Lab] SGN survo — VendorInvestigate came back 99.0% against a claimed 99.1%

Cautionbranch of 9 comments

Posting this because I searched for it and got nothing useful. Setup: 7.5mg, week 45, constipation present but not ruining anything. I changed exactly one variable — biopsy — and tracked it for 8 weeks. Result: a difference, but a small one, and well inside what I would call noise if someone else posted it. So I am…

Read the full submission and all 66 comments →

This branch

9 comments, started 9 months ago
u/old_account_2023143 points·9 months ago

This is correct. Do not generalise from tirzepatide.

replysharereportpermalink
[removed]103 points·9 months ago

[removed by moderator]

replysharereportpermalink
u/kaia_wojcik52 points·9 months ago·edited

[removed by moderator]

Disagree on that part. 98.1% and 95.1% on the same vial is normal.

replysharereportpermalink
u/hana_pereira108 points·9 months ago

Not convinced. The evidence does not support that reading.

replysharereportpermalink
u/hana_lehtinen90 points·9 months ago

glucagon injection is a different vector than GLP-1

replysharereportpermalink
load more comments (4) →

← back to the whole thread

About c/survodutide

Survodutide-specific discussion: glucagon-receptor co-agonism, the hepatic fat and MASH resolution data, and how the side-effect profile compares with GIP-based dual agonism. Small community, high signal.

12kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/survodutide
c/survodutide rules
  1. Glucagon co-agonism has a distinct safety story. Do not generalise from tirzepatide.
  2. MASH claims need the trial and the biopsy endpoint.
  3. Not approved. Descriptive posts only.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/incretin_ivyu/liver_enzyme_lizu/trialwatch_theo
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →